Cambridge Investment Research Advisors’s iShares MSCI USA Quality GARP ETF GARP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$34.3M Buy
536,662
+7,046
+1% +$478K 0.09% 219
2025
Q4
$36.1M Buy
529,616
+39,115
+8% +$2.63M 0.1% 205
2025
Q3
$32.2M Buy
490,501
+28,975
+6% +$1.81M 0.09% 225
2025
Q2
$27.9M Buy
461,526
+113,500
+33% +$6.18M 0.08% 241
2025
Q1
$17.8M Buy
348,026
+151,190
+77% +$8.45M 0.06% 320
2024
Q4
$11.1M Buy
196,836
+26,466
+16% +$1.46M 0.04% 451
2024
Q3
$9.1M Buy
170,370
+23,307
+16% +$1.2M 0.03% 544
2024
Q2
$7.63M Buy
+147,063
New +$7.1M 0.03% 569

Other funds holding GARP

Cambridge Investment Research Advisors's GARP Position: Q1 2026 in Review

Cambridge Investment Research Advisors increased its iShares MSCI USA Quality GARP ETF (GARP) stake by 1.3% in Q1 2026, buying an estimated $478K and bringing the position to 536,662 shares worth $34.3M. The position accounts for 0.09% of the portfolio, ranked #219.

Cambridge Investment Research Advisors first reported a position in GARP in Q2 2024 and has held it in 8 quarters since. The position peaked at $36.1M in Q4 2025. 139 funds tracked by Wall St. Rank hold GARP as of Q1 2026.

  • Cambridge Investment Research Advisors held 536,662 shares of iShares MSCI USA Quality GARP ETF worth $34.3M as of Q1 2026.
  • Cambridge Investment Research Advisors bought 7,046 iShares MSCI USA Quality GARP ETF shares in Q1 2026, an estimated $478K.
  • iShares MSCI USA Quality GARP ETF made up 0.09% of Cambridge Investment Research Advisors's portfolio in Q1 2026, its #219 holding.
  • Cambridge Investment Research Advisors first reported a position in iShares MSCI USA Quality GARP ETF in Q2 2024 and has held it in 8 quarters since.
  • Cambridge Investment Research Advisors's iShares MSCI USA Quality GARP ETF position peaked at $36.1M in Q4 2025.
  • 139 funds tracked by Wall St. Rank held iShares MSCI USA Quality GARP ETF as of Q1 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.